Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 4:08 PM
Ignite Modification Date: 2025-12-25 @ 2:09 PM
NCT ID: NCT04049266
Term: Retinal haemorrhage - Study eye
Organ System: Eye disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA version 23.1
Notes: None
Study: NCT04049266
Study Brief: A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 18 17 277 View
EG001 5 4 280 View